XML 107 R83.htm IDEA: XBRL DOCUMENT v3.6.0.2
Long-term Equity-based Compensation - Activity Related to Nonvested Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Feb. 04, 2017
Feb. 04, 2016
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Total fair value of DSUs that vested during the years     $ 0.5 $ 0.1 $ 0.2
Annual Awards of Deferred Stock Units to be Issued to each Non-Employee Director       500 500
Initial grant for non-employee director, shares       4,000 4,000
Automatic annual grant, non-employee directors, options       4,000 4,000
Automatic annual grant, non-employee directors, options, expiration date       10 years 10 years
Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vested in Period, Total Fair Value     1.3 $ 1.4 $ 3.6
Income tax benefit from share-based compensation     $ 0.5 $ 0.5 $ 1.2
Time Vested Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Nonvested Balance at Beginning of Year, Restricted Shares     29,448    
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value (per share)     $ 33.77    
Grants in Period     0    
Grants in Period, Weighted Average Grant Date Fair Value (per share)     $ 0.00    
Vested in Period     (12,098)    
Vested in Period, Weighted Average Grant Date Fair Value (per share)     $ 32.32    
Forfeited in Period     (1,350)    
Forfeited in Period, Weighted Average Grant Date Fair Value (per share)     $ 35.75    
Nonvested Balance at End of Year, Restricted Shares     16,000 29,448  
Nonvested at End of Year, Weighted Average Grant Date Fair Value (per share)     $ 34.69 $ 33.77  
Performance Based Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Performance period     3 years    
Nonvested Balance at Beginning of Year, Restricted Shares     51,400    
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value (per share)     $ 42.12    
Grants in Period     0    
Grants in Period, Weighted Average Grant Date Fair Value (per share)     $ 0.00    
Forfeited in Period     (51,400)    
Forfeited in Period, Weighted Average Grant Date Fair Value (per share)     $ 42.12    
Nonvested Balance at End of Year, Restricted Shares     0 51,400  
Nonvested at End of Year, Weighted Average Grant Date Fair Value (per share)     $ 0.00 $ 42.12  
Reduction in share authorization if maximum performance level is met or exceeded (shares)     682,752    
Time Vested Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Nonvested Balance at Beginning of Year, Restricted Shares     85,048    
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value (per share)     $ 36.84    
Grants in Period     118,622    
Grants in Period, Weighted Average Grant Date Fair Value (per share)     $ 31.48    
Vested in Period     (26,006)    
Vested in Period, Weighted Average Grant Date Fair Value (per share)     $ 33.01    
Forfeited in Period     (19,303)    
Forfeited in Period, Weighted Average Grant Date Fair Value (per share)     $ 36.03    
Nonvested Balance at End of Year, Restricted Shares     158,361 85,048  
Nonvested at End of Year, Weighted Average Grant Date Fair Value (per share)     $ 33.56 $ 36.84  
Performance Based Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Nonvested Balance at Beginning of Year, Restricted Shares     128,100    
Nonvested at Beginning of Year, Weighted Average Grant Date Fair Value (per share)     $ 41.85    
Grants in Period     146,788    
Grants in Period, Weighted Average Grant Date Fair Value (per share)     $ 29.62    
Forfeited in Period     (47,304)    
Forfeited in Period, Weighted Average Grant Date Fair Value (per share)     $ 39.04    
Nonvested Balance at End of Year, Restricted Shares     227,584 128,100  
Nonvested at End of Year, Weighted Average Grant Date Fair Value (per share)     $ 34.55 $ 41.85  
Performance Period, 2015 to 2017 [Member] | Performance Based Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of Additional Shares To Be Granted If Maximum Perfornance Level Is Met or Exceeded     46,762    
Reduction in share authorization if maximum performance level is met or exceeded (shares)     412,845    
Performance Period, 2014 to 2016 [Member] | Performance Based Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Reduction in share authorization if maximum performance level is met or exceeded (shares)     140,286    
Performance Period, 2013 to 2015 [Member] | Performance Based Restricted Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock Issued During Period, Shares, Share-based Compensation, Forfeited   51,400      
Subsequent Event [Member] | Performance Period, 2014 to 2016 [Member] | Performance Based Restricted Stock Units [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Forfeited in Period (43,207)        
Director [Member] | Stock Options [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     0 years 5 years 6 months 6 years